Effects of the combined artesunate and mefloquine antimalarial drugs on rat embryos

被引：8

作者：

Boareto, A. C. ^{[1
]}

Mueller, J. C. ^{[1
]}

Lourenco, E. L. B. ^{[1
]}

Lombardi, N. ^{[1
]}

Lourenco, A. C. ^{[1
]}

Rabitto, I. ^{[1
]}

de Morais, R. N. ^{[2
]}

Rios, F. S. ^{[3
]}

Dalsenter, P. R. ^{[1
]}

机构：

[1] Univ Fed Parana, Dept Pharmacol, BR-81531990 Curitiba, Parana, Brazil

[2] Univ Fed Parana, Dept Physiol, BR-81531990 Curitiba, Parana, Brazil

[3] Univ Fed Parana, Dept Cell Biol, BR-81531990 Curitiba, Parana, Brazil

来源：

HUMAN & EXPERIMENTAL TOXICOLOGY | 2013年 / 32卷 / 09期

关键词：

Artesunate; mefloquine; antimalarial; embryolethality; histopathology; DEVELOPMENTAL TOXICITY; FALCIPARUM-MALARIA; DIHYDROARTEMISININ DHA; COMBINATION THERAPY; PREGNANCY; ARTEMISININ; TERATOGENICITY; FAILURE; PERIODS; SAFETY;

D O I：

10.1177/0960327113475678

中图分类号：

R99 [毒物学（毒理学）];

学科分类号：

100405 ;

摘要：

Artemisinins combination therapy (ACT) is the first choice therapy for falciparum malaria. Data on the safety of ACTs in pregnancy are limited and controversial and the use is not recommended on the first trimester. To evaluate the effects of isolated and combined artesunate (AS)/mefloquine (MQ) on embryo rats, pregnant rats were treated orally with AS (15 and 40mg/kg body weight (bwt)/day), MQ (30 and 80mg/kg bwt/day) and AS/MQ (15/30 and 40/80mg/kg bwt/day) on days 9-11 post coitum (pc). The dams were euthanized on day 12 pc and gestational and embryos histological parameters were evaluated. Embryolethality and histopathological anomalies were significant when AS was given alone or combined with MQ. Combination of AS and MQ did not enhance their toxicity compared to their separate administrations; on the other side, there was a reduction in the toxic effects of the AS when combined with MQ. Isolated MQ did not induce developmental toxicity.

引用

页码：930 / 941

页数：12

共 33 条

[1] Antimalarial drug toxicity: A review [J].

Alkadi, Hussien O. .

CHEMOTHERAPY, 2007, 53 (06) :385-391

[2]

[Anonymous], 2010, Guidelines for the treatment of Malaria, DOI DOI 10.1080/03630269.2023.2168201

[3] Histopathology in fish: proposal for a protocol to assess aquatic pollution [J].

Bernet, D ;

Schmidt, H ;

Meier, W ;

Burkhardt-Holm, P ;

Wahli, T .

JOURNAL OF FISH DISEASES, 1999, 22 (01) :25-34

[4] Toxicity of artemisinin [Artemisia annua L.] in two different periods of pregnancy in Wistar rats [J].

Boareto, Ana C. ;

Muller, Juliane C. ;

Bufalo, Aedra C. ;

Botelho, Giuliana G. K. ;

de Araujo, Samanta L. ;

Foglio, Mary Ann ;

de Morais, Rosana N. ;

Dalsenter, Paulo R. .

REPRODUCTIVE TOXICOLOGY, 2008, 25 (02) :239-246

[5] Antimalarial artemisinin drugs induce cytochrome p450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor [J].

Burk, O ;

Arnold, KA ;

Nussler, AK ;

Schaeffeler, E ;

Efimova, E ;

Avery, BA ;

Avery, MA ;

Fromm, MF ;

Eichelbaum, M .

MOLECULAR PHARMACOLOGY, 2005, 67 (06) :1954-1965

[6]

CHEN LJ, 1984, ACTA PHARMACOL SIN, V5, P118

[7] Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit [J].

Clark, RL ;

White, TEK ;

Clode, SA ;

Gaunt, I ;

Winstanley, P ;

Ward, SA .

BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY, 2004, 71 (06) :380-394

[8] Artesunate: Developmental toxicity and toxicokinetics in monkeys [J].

Clark, Robert L. ;

Arima, Akihiro ;

Makori, Norbert ;

Nakata, Yasuto ;

Bernard, Frederic ;

Gristwood, William ;

Harrell, Andrew ;

White, Tacey E. K. ;

Wier, Patrick J. .

BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY, 2008, 83 (04) :418-434

[9] Embryotoxicity of the artemisinin antimalarials and potential consequences for use in women in the first trimester [J].

Clark, Robert L. .

REPRODUCTIVE TOXICOLOGY, 2009, 28 (03) :285-296

[10] Ontogeny of the hematopoietic system [J].

Cumano, Ana ;

Godin, Isabelle .

ANNUAL REVIEW OF IMMUNOLOGY, 2007, 25 :745-785

← 1 2 3 4 →